The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Plasma Protein Therapeutic Market Report By Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor And Others), Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2028
ID:VMR11210720
March 2022
Report Formats: Electronic (PDF), MS EXCEL
As per this study, the Global Plasma Protein Therapeutic Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.
Plasma protein therapeutic comprises of plasma-derived and recombinant analog therapies. These involve the treatment of various rare, life-threatening, chronic and genetic diseases. Some of the diseases that can be treated by using plasma protein therapeutic include bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis and infectious diseases such as tetanus, hepatitis, and rabies. Immunoglobulins, albumin, coagulation factors, and alpha-1 proteinase inhibitor are types of plasma protein therapeutic.
Market Dynamics
The increasing applications of plasma proteins in the pharmaceutical industry are driving market growth. Additionally, growing expenditure in the healthcare industry along with the introduction of new plasma-based therapies is further fuelling market growth. On the other hand, slower approval procedure and implementation of stringent regulation policies may restrict market growth. Whereas, increasing demand for plasma-based therapies in emerging economies is expected to create potential opportunity during the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma protein therapeutic.
Market Segmentation
The broad plasma protein therapeutic market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
By Application
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma protein therapeutic in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Plasma Protein Therapeutic Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma protein therapeutic market include Baxter, Biotest, Chengdu Inst., China Biologics, CSL Behring, Grifols, Kedrion, Octapharma, and Shire Plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
Plasma protein therapeutic comprises of plasma-derived and recombinant analog therapies. These involve the treatment of various rare, life-threatening, chronic and genetic diseases. Some of the diseases that can be treated by using plasma protein therapeutic include bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis and infectious diseases such as tetanus, hepatitis, and rabies. Immunoglobulins, albumin, coagulation factors, and alpha-1 proteinase inhibitor are types of plasma protein therapeutic.
Market Dynamics
The increasing applications of plasma proteins in the pharmaceutical industry are driving market growth. Additionally, growing expenditure in the healthcare industry along with the introduction of new plasma-based therapies is further fuelling market growth. On the other hand, slower approval procedure and implementation of stringent regulation policies may restrict market growth. Whereas, increasing demand for plasma-based therapies in emerging economies is expected to create potential opportunity during the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma protein therapeutic.
Market Segmentation
The broad plasma protein therapeutic market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
- Immunoglobulins
- Albumin
- Coagulation Factors
- Alpha-1 proteinase inhibitor
- Others
By Application
- Hemophilia
- Primary Immunodeficiency Disorder
- Idiopathic Thrombocytopenic Purpura
- Secondary Immunodeficiency
- Others
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma protein therapeutic in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Plasma Protein Therapeutic Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma protein therapeutic market include Baxter, Biotest, Chengdu Inst., China Biologics, CSL Behring, Grifols, Kedrion, Octapharma, and Shire Plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . PLASMA PROTEIN THERAPEUTIC – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Immunoglobulins Historic and Forecast Sales by Regions
6.6 Albumin Historic and Forecast Sales by Regions
6.5 Coagulation Factors Historic and Forecast Sales by Regions
6.7 Alpha-1 proteinase inhibitor Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions
7 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Hemophilia Historic and Forecast Sales by Regions
7.5 Primary Immunodeficiency Disorder Historic and Forecast Sales by Regions
7.6 Idiopathic Thrombocytopenic Purpura Historic and Forecast Sales by Regions
7.7 Secondary Immunodeficiency Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1. Overview, Historic and Forecast Sales Analysis
8.3.2. North America By Segment Sales Analysis
8.3.3. North America By Country Sales Analysis
8.3.4. United State Sales Analysis
8.3.5. Canada Sales Analysis
8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1. Overview, Historic and Forecast Sales Analysis
8.4.2. Europe by Segment Sales Analysis
8.4.3. Europe by Country Sales Analysis
8.4.4. United Kingdom Sales Analysis
8.4.5. France Sales Analysis
8.4.6. Germany Sales Analysis
8.4.7. Italy Sales Analysis
8.4.8. Russia Sales Analysis
8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1. Overview, Historic and Forecast Sales Analysis
8.5.2. Asia Pacific by Segment Sales Analysis
8.5.3. Asia Pacific by Country Sales Analysis
8.5.4. China Sales Analysis
8.5.5. India Sales Analysis
8.5.6. Japan Sales Analysis
8.5.7. South Korea Sales Analysis
8.5.8. Australia Sales Analysis
8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1. Overview, Historic and Forecast Sales Analysis
8.6.2. Latin America by Segment Sales Analysis
8.6.3. Latin America by Country Sales Analysis
8.6.4. Brazil Sales Analysis
8.6.5. Argentina Sales Analysis
8.6.6. Peru Sales Analysis
8.6.7. Chile Sales Analysis
8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1. Overview, Historic and Forecast Sales Analysis
8.7.2. Middle East & Africa by Segment Sales Analysis
8.7.3. Middle East & Africa by Country Sales Analysis
8.7.4. Saudi Arabia Sales Analysis
8.7.5. UAE Sales Analysis
8.7.6. Israel Sales Analysis
8.7.7. South Africa Sales Analysis
8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE PLASMA PROTEIN THERAPEUTIC COMPANIES
9.1. Plasma Protein Therapeutic Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF PLASMA PROTEIN THERAPEUTIC INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Baxter
10.3.1. Company Overview
10.3.2. Company Revenue
10.3.3. Products
10.3.4. Recent Developments
10.4. Biotest
10.4.1. Company Overview
10.4.2. Company Revenue
10.4.3. Products
10.4.4. Recent Developments
10.5. Chengdu Inst.
10.5.1. Company Overview
10.5.2. Company Revenue
10.5.3. Products
10.5.4. Recent Developments
10.6. China Biologics
10.6.1. Company Overview
10.6.2. Company Revenue
10.6.3. Products
10.6.4. Recent Developments
10.7. CSL Behring
10.7.1. Company Overview
10.7.2. Company Revenue
10.7.3. Products
10.7.4. Recent Developments
10.8. Grifols
10.8.1. Company Overview
10.8.2. Company Revenue
10.8.3. Products
10.8.4. Recent Developments
10.9. Kedrion
10.9.1. Company Overview
10.9.2. Company Revenue
10.9.3. Products
10.9.4. Recent Developments
10.10. Octapharma
10.10.1. Company Overview
10.10.2. Company Revenue
10.10.3. Products
10.10.4. Recent Developments
10.11. Shire Plc.
10.11.1. Company Overview
10.11.2. Company Revenue
10.11.3. Products
10.11.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Type (USD MN)
- Immunoglobulins Market Sales by Geography (USD MN)
- Albumin Market Sales by Geography (USD MN)
- Coagulation Factors Market Sales by Geography (USD MN)
- Alpha-1 proteinase inhibitor Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Hemophilia Market Sales by Geography (USD MN)
- Primary Immunodeficiency Disorder Market Sales by Geography (USD MN)
- Idiopathic Thrombocytopenic Purpura Market Sales by Geography (USD MN)
- Secondary Immunodeficiency Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Plasma Protein Therapeutic Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Plasma Protein Therapeutic Report
- Market Research Process
- Market Research Methodology
- Global Plasma Protein Therapeutic Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Immunoglobulins Market Sales by Geography (USD MN)
- Albumin Market Sales by Geography (USD MN)
- Coagulation Factors Market Sales by Geography (USD MN)
- Alpha-1 proteinase inhibitor Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Hemophilia Market Sales by Geography (USD MN)
- Primary Immunodeficiency Disorder Market Sales by Geography (USD MN)
- Idiopathic Thrombocytopenic Purpura Market Sales by Geography (USD MN)
- Secondary Immunodeficiency Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare IT
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments